Optimizing Cardioprotection and CV Risk Reduction in Primary and Familial Hypercholesterolemia (FH): How Do We Address the Need for Improved LDL-Targeted Atheroprotection in High Risk Populations? What Works? How Well? What Doesn’t Work? Why? - Jennifer G. Robinson, MD, MPH